Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-02-10
2010-11-23
Noakes, Suzanne M. (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07838493
ABSTRACT:
The present invention describes the use of an AChE-R-derived peptide, also known as ARP, as an inducer of hemopoietic cell differentiation and expansion, specifically for the granulocytic population. In addition, the use of ARP as an inducer of thrombopoietin and pro-inflammatory cytokines is also presented. ARP may further be used in the pre-transplant priming of hematopoietic stem cells. Other uses and methods utilizing ARP are also described herein.
REFERENCES:
patent: 2003/0036632 (2003-02-01), Soreq et al.
patent: 130224 (2004-02-01), None
patent: WO-00/73427 (2000-12-01), None
Abo, T. and Kawamura, T., Ther. Apher., 2002, pp. 348-357, vol. 6.
Abramson, N. and Melton, B., Am. Fam. Physician, 2000, pp. 2053-2060., vol. 62.
Basser, R.L. et al., Blood, 2002, pp. 2599-2602, vol. 99.
Bassini, A. et al., Blood, 1999, pp. 1178-1188, vol. 93.
Birikh, K.R. et al, RNA Society, 1997, pp. 429-437, vol. 3.
Borovikova, L.V. et al., Nature, 2000, pp. 458-462, vol. 405.
Brenner et al., FASEB J, 2003, pp. 214-22, vol. 17(2).
Busslinger, M., Ann. Rev. Immunol., 2004, pp. 55-79, vol. 22.
Chan, R.Y.Y. et al., J. Biol. Chem., 1998, pp. 9727-9733, vol. 273.
Craig, W. et al., Br. J. Haematol, 1994, pp. 24-30, vol. 88.
Delgado, I. et al., Gynecol. Obstet. Invest., 1994, pp. 227-235, vol. 38.
Deutsch, V. et al., Exp. Hematol., 2002, pp. 1153-1161, vol. 30.
Erb, C. et al., J. Neurochem., 2001, pp. 638-646, vol. 77.
Flores-Flores, C. et al., J. Neural Transm., 2002, pp. 165-179, vol. 62(supp).
Gainsford, T. et al., Blood, 2000, pp. 528-534, vol. 95.
Grisaru, D. et al., Mol. Cell Biol., 1999, pp. 788-795, vol. 19.
Grisaru, D. et al., Molecular Medicine, 2001, pp. 93-105, vol. 7.
Guenechea, G. et al., Blood, 1999, pp. 1097-1105, vol. 93.
Hanada and Yoshimura, Cytokine Growth Factor Rev., 2002, pp. 413-421, vol. 13.
Hellstrom-Lindahl, E. and Nordberg, A., J. Neuroimmunol., 1996, pp. 139-144, vol. 68.
Ishibashi, T. et al., Proc. Natl. Acad. Sci. U.S.A., 1989, pp. 5953-5957, vol. 86.
Jackson, C.W., Blood, 1973, pp. 413-421, vol. 42.
Johnsson, B. et al., Anal. Biochem., 1991,pp. 268-277, vol. 198.
Kanamaru, S. et al, Stem Cells, 2000, pp. 190-195, vol. 18.
Kaser, A. et al., Blood, 2001, pp. 2720-2725, vol. 98.
Kawashima, K. and Fuji, T., Pharmacol Ther., 2000, pp. 29-48, vol. 86.
Kiecolt-Glaser, J.K. et al., Proc. Natl. Acad. Sci. U.S.A., 2003, pp. 9090-9095, vol. 100.
Kuter, D.J., Transfusion, 2002, pp. 279-283, vol. 42.
Lagasse, E. and Weissman, I.L., J. Immunol. Methods, 1996, pp. 139-150, vol. 197.
Lev-Lehman, E. et al., Blood, 1997, pp. 3644-3653, vol. 89.
Li, K. et al., Br. J. Haematol., 1999, pp. 178-185, vol. 104.
Li, Y. et al., J. Neurosci., 2000, pp. 149-155, vol. 20.
Marchisio, M. et al., Anat. Rec., 1999, pp. 7-14, vol. 255.
Mastorakos, G. and Ilias, I., Ann. NY Acad. Sci., 2000, pp. 95-106, vol. 900.
Miller, G.E. et al., Health Psychol., 2002, pp. 531-541, vol. 21.
Mita, Y. et al., Eur. J. Pharmacol., 1996, pp. 121-127, vol. 297.
Nagata, Y. et al., Thromb. Haemost., 1997, pp. 808-814, vol. 77.
Nakashima, K. et al., Semin Hematol., 1998, pp. 210-221, vol. 35.
Nitsche, A. et al., Haematologica, 2001, pp. 693-699, vol. 86.
Oshevski, S. et al., Biochem. Biophys. Res. Commun., 1999, pp. 603-609, vol. 263.
Perry, C. et al., Neoplasia, 2004, pp. 279-286, vol. 6(3).
Pick, M. et al., Br. J. Haematol., 1998, pp. 639-650, vol. 103.
Pick, M. et al., Ann. NY Acad. Sci., 2004, pp. 85-95, vol. 1018.
Pick, M. et al., Exp. Hematol., 2002, p. 1079, vol. 30.
Porcellini, A. et al., Int. J. Cell Cloning, 1983, pp. 92-104, vol. 1.
Racke, F.K. et al., J. Biol. Chem., 2001, pp. 522-528, vol. 276.
Reizenstein, P., Br. J. Haematol., 1979, pp. 329-334, vol. 43.
Rojnuckarin, P. et al., Blood, 2001, pp. 154-161, vol. 97.
Rojnuckarin, P. et al., J. Biol. Chem., 2001, pp. 41014-41022, vol. 276.
Sklan, E.H. et al., Proc. Natl. Acad. Sci. U.S.A., 2004, pp. 5512-5517, vol. 101(15).
Soreq, H. and Seidman, S., Nat. Rev. Neurosci., 2001, pp. 294-302, vol. 2.
Sternfeld, M. et al., J. Neurosci., 1998, pp. 1240-1249, vol. 18.
Sternfeld, M. et al., J. Physiol. Paris, 1998, pp. 249-255, vol. 92.
Sternfeld, M. et al., Proc. Natl. Acad. Sci. U.S.A., 2000, pp. 8647-8652, vol. 97.
Stowe, R. P. et al., J. Leukoc. Biol., 1999, pp. 179-186, vol. 65.
Szelenyi et al., Immunol. Letter, 1987, pp. 49-54, vol. 16.
Szelenyi et al., Br. J. Haematol., 1982, pp. 241-245, vol. 50.
Tavassoli, M., Blood Cells, 1991, pp. 269-281, vol. 17.
Teramura, M. et al., Cancer Chemother. Pharmacol., 1996, pp. S99-S102, vol. 38(supp).
Toft, P. et al., Apmis, 1994, pp. 43-48, vol. 102.
Topilko and Caillou, Blood, 1985, pp. 891-895, vol. 66.
Tracey, K.J., Nature, 2002, pp. 853-859, vol. 420.
Tuimala, R. et al., Br. J. Obstret. Gynecol., 1976, pp. 707-710, vol. 83.
Wanahita, A. et al., Clin. Infect. Dis.,2002, pp. 1585-1592, vol. 34.
Wang, H. et al., Nature, 2003, pp. 384-388, vol. 421.
Wilson et al., J. Am. Geriatr. Soc., 2002, pp. 2041-2056, vol. 50.
Xu, Z. and Weiss, A., Nat. Immunol., 2002, pp. 764-771, vol. 3.
Zahorec, R., Bratisl. Lek. Listy., 2001, pp. 5-14, vol. 102.
Zhang, X.J. et al., Cell Death Differ., 2002, pp. 790-800, vol. 9.
Deutsch, V. et al., Blood, 2001, p. 73a, vol. 91 (11—part1).
International Search Report for PCT/IL05/000185.
International Prelim Report on Patentability for PCT/IL05/000185.
Deutsch Varda
Grisaru Dan
Perry Chava
Pick Marjorie
Soreq Hermona
Bianco Paul D.
Fleit Martin
Fleit Gibbons Gutman Bongini & Bianco PL
Medical Research Fund at the Tel Aviv Sourasky Medical Center
Noakes Suzanne M.
LandOfFree
Acetylcholinesterase (ACHE)-derived peptide as an inducer of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acetylcholinesterase (ACHE)-derived peptide as an inducer of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acetylcholinesterase (ACHE)-derived peptide as an inducer of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4207797